USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Emerging Therapeutics in the U.S. Colorectal Cancer Markets
29-Apr-2006
North America
Market Research
F205-01-00-00-00
HC01429-NA-MR_05888
Emerging Therapeutics in the U.S. Colorectal Cancer Market is a rapidly progressing field that is set to generate over $2 billion in revenue in the coming years. The market has witnessed unprecedented growth with the launch of a new segment and as a result competition has increased in the cytotoxic market. The dynamics of this market are changing rapidly and the forecast through 2011 highlights the major changes. This study includes patient forecasts, pipeline analysis and individual product revenue forecasts.
Emerging Therapeutics in the U.S. Colorectal Cancer Markets, U.S. Total Market for Colorectal Cancer
Executive Summary
- Executive Summary - Updated 4/2006
Research Scope and Methodology
- Scope and Segmentation
- Research Methodology
Disease Overview
- Introduction
- Etiology
- Screening
- Diagnosis and Staging
- Treatment Overview
Patient Forecasts
- Incidence and Staging Forecasts
- Patient Forecasts by Line of Therapy
- Unmet Need Population Forecasts
Total Market Forecasts
- Total Market Forecasts - Updated 4/2006
- Market Share Analysis - Updated 4/2006
- Adjuvant Therapy Forecasts - Updated 4/2006
- First-line Therapy Forecasts - Updated 4/2006
- Second and Third-line Therapy Forecasts - Updated 4/2006
General Market Trends
- Industry Challenges
- Market Drivers
- Market Restraints
Frost & Sullivan Awards
- Company of the Year Award
- Product of the Year Award
- Entrepreneurial Company of the Year Award
- Product Differentiation Innovation of the Year Award
- Best Bang for the Buck Award
Overview
Forecasts and Trends
Competitive Analysis
Overview
Angiogenesis Pathway
EGF Pathway
Cell Proliferation/Apoptosis Pathway
Immune Response Pathway
Revenue Forecasts
Competitive Analysis
Decision Support Databases
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
16 Oct 2026 | Global | Market Research
Public Sector Healthcare Cloud Market, North America and Europe, 2026
Public healthcare organizations across North America and Europe are using cloud technologies to support modernization efforts that extend beyond infrastructure replacement. Cloud is increasingly being adopted to improve interoperability, enable secure data sharing, support analytics and AI initiativ...
16 Oct 2026 | Global | Technology Research
Innovations and Growth Opportunities in Precision Therapeutics, AI-Enabled Discovery and Bioengineering, Regenerative Medicine, and Next-Generation Vaccine Platforms
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming precision therapeutics, regenerative medicine, AI-enabled discovery, laboratory automation, targeted delivery, vaccines, and biomanufactu...
15 Oct 2026 | Global | Frost Radar
Frost Radar™: US and European Mammalian Contract Development and Manufacturing Organizations, 2026
The US and European mammalian contract development and manufacturing organization (CDMO) market is entering a new phase of strategic evolution, driven by accelerating biologics outsourcing, increasing molecule complexity, and growing demand for resilient, end-to-end manufacturing partnerships. As mo...
08 Oct 2026 | Global | Frost Radar
Frost Radar: Endoscopy Device Technology Ecosystem, 2026
The endoscopy device market is advancing toward higher-quality visualization and improved clinical decision-making, with innovation across 4K ultrahigh-definition display systems, image-enhanced endoscopy, and computer-aided detection systems. Advanced visualization is evolving through improvements ...
07 Oct 2026 | Global | Technology Research
Growth Opportunities in Image-Guided Cancer Ablation Systems
Image-guided cancer ablation systems are minimally invasive medical technologies that use real-time imaging to accurately guide the placement of an ablation device into a tumor, enabling localized destruction of cancerous tissue while minimizing damage to surrounding healthy structures.The increasin...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.